REQUEST A DEMO
Total
USD $0.00
Search more companies

Cyclolab Kft. (Hungary)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Secondary Activities: Chemical and Allied Products Merchant Wholesalers | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: CYCLOLAB, Ciclodextrin Kutato-Fejleszto Kft. Profile Updated: February 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Cyclolab Kft. is an enterprise located in Hungary, with the main office in Budapest. The enterprise operates in the Research and Development in the Physical, Engineering, and Life Sciences industry. It was first established on December 05, 1991. 59 (2023) employees currently work for Cyclolab Kft.. In its most recent financial highlights, the company reported a net sales revenue drop of 5.79% in 2022. Its’ total assets recorded a growth of 43.64%. Cyclolab Kft.’s net profit margin increased by 22.99% in 2022.

Headquarters
Illatos ut 7.
Budapest; Budapest; Postal Code: 1097

Contact Details: Purchase the Cyclolab Kft. report to view the information.

Website: http://www.cyclolab.hu

Basic Information
Total Employees:
Purchase the Cyclolab Kft. report to view the information.
Outstanding Shares:
Purchase the Cyclolab Kft. report to view the information.
Registered Capital:
Purchase the Cyclolab Kft. report to view the information.
Financial Auditors:
Purchase the Cyclolab Kft. report to view the information.
Incorporation Date:
December 05, 1991
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Subsidiaries
Cf Pharma Kft.
Targetrin Therapeutics Kft. v.a.
Company Performance
Financial values in the chart are available after Cyclolab Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-5.79%
Total operating revenue
-4.47%
Operating profit (EBIT)
19.41%
EBITDA
20.63%
Net Profit (Loss) for the Period
29.95%
Total assets
43.64%
Total equity
-40.61%
Operating Profit Margin (ROS)
14.59%
Net Profit Margin
22.99%
Return on Equity (ROE)
37.55%
Quick Ratio
-18.55%
Cash Ratio
-17.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?